Available — All Storefronts

Weight Loss — GLP-1s

The category that redefined what's possible in telehealth. CareValidate gives your storefront everything it needs to launch a fully operational and scalable GLP-1 program — clinical infrastructure, pharmacy access, and compliant provider workflows — without building any of it yourself.

Weight Loss — GLP-1s

About This Category

GLP-1s are the most in-demand prescription category in consumer health right now, and for good reason. Semaglutide and tirzepatide work by mimicking hormones that regulate appetite and blood sugar, helping patients feel full longer, reduce caloric intake, and support meaningful changes in body composition.

When you launch GLP-1s through CareValidate, you're getting a complete clinical pathway out of the box: intake form, async provider review, compliant prescribing, and pharmacy fulfillment. Your brand runs the storefront. We handle the clinical and operational infrastructure behind it.

Why Weight Loss — The Business Case

$100B+

Projected global GLP-1 market by 2030, up from ~$24B in 2023

42%

of U.S. adults are obese — over 100 million people in the addressable market

#1

Most searched and prescribed telehealth category since 2023

In just a few years, the GLP-1 category exploded. This created a massive, underserved market that DTC health brands are uniquely positioned to serve.

The demand is real and durable: weight management is a chronic, recurring need, not a one-time purchase. Patients on GLP-1 medications typically stay on them for months or years, creating strong LTV and subscription retention. The category also generates significant word-of-mouth, results that are visible drive referrals organically.

For brands launching on CareValidate, this is the category to lead with. It has the widest addressable market, the clearest patient motivation, the most proven conversion funnel in DTC telehealth, and the highest revenue potential per patient. If you're only going to launch one category, this is it.

Clinical Pathway

Intake Form

Patient completes health questionnaire covering medical history, current medications, and weight goals.

Provider Review

Licensed clinician reviews intake.

Pharmacy Fulfillment

Medication dispensed from a U.S.-licensed pharmacy and shipped to the patient.

Prescription Issued

If appropriate, provider prescribes GLP-1 with a titration dosing schedule.

Formulary and Forms

Drug Molecule Available Forms
Semaglutide GLP-1 agonist Injectable Oral / ODT Microdose
Tirzepatide Dual GIP/GLP-1 agonist ref: Mounjaro® / Zepbound® Injectable Oral / ODT Microdose
HIPAA
SOC2 Type II
LegitScript

Pharmacy fulfillment, handled

One platform. Total compliance. Let's build your prescription program together.

Book a Demo →